| chickenpox vaccine | <pharmacology, virology> A live-varicella virus vaccine. Limited clinical trials suggest the immunity lasts for at least six years. The only significant adverse reaction detected in clinical studies was pain and redness at the injection site. Children (or adults) with a history for an anaphylactoid reaction to neomycin or gelatin or the presence of any febrile illness, should not be given the vaccine. Pregnant women and those who are immunocompromised should also not receive the vaccine. It is furthermore recommended that pregnancy be avoided for 3 months following vaccination. In trials involving 9,000 children, 80% were protected and 20% reported mild cases. It is recommended for children between the ages of 12 months and 13 years. (12 Dec 1998) |
|---|---|
| rickettsia vaccine | Attenuated See: typhus vaccine. (05 Mar 2000) |
| pertussis vaccine | A suspension of killed bordetella pertussis organisms, used for immunization against pertussis (whooping cough). It is generally used in a mixture with diphtheria and tetanus toxoids (dtp). There is an acellular pertussis vaccine prepared from the purified antigenic components of bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (12 Dec 1998) |
| cholera vaccine | A killed bacteria vaccine containing equal portions of the inaba and ogawa strains of vibrio cholerae, used for immunization against cholera. It enhances protection in adults for about six months, but does not reduce faecal shedding of bacteria or reduce disease transmission. Other cholera vaccines are under development. (12 Dec 1998) |
| Rocky Mountain spotted fever vaccine | Suspension of inactivated Rickettsia rickettsii prepared by growing the rickettsiae in the embryonate yolk sac of fowl eggs. (05 Mar 2000) |
| rubella vaccine | A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunised and do not have serum antibodies to rubella. Children are usually immunised with measles-mumps-rubella combination vaccine. (12 Dec 1998) |
| rubella virus vaccine | A live virus vaccine prepared from duck embryo or human diploid cell culture infected with rubella virus; administered as a single subcutaneous injection. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| MMR vaccine | <drug> The mumps, measles and rubella vaccine is recommended in all infants. Typically given twice, 15 months and at 4-6 years. (27 Sep 1997) |
| plague vaccine | A suspension of killed yersinia pestis used for immunizing people in enzootic plague areas. (12 Dec 1998) |
| whooping-cough vaccine | See: diphtheria toxoid, tetanus toxoid, and pertussis vaccine. (05 Mar 2000) |
| multivalent vaccine | A vaccine prepared from cultures of two or more strains of the same species or microorganism. Synonym: multivalent vaccine. (05 Mar 2000) |
| mumps vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunised with live mumps vaccine. Children are usually immunised with measles-mumps-rubella combinatiom vaccine. (12 Dec 1998) |
| mumps virus vaccine | Vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| pneumococcal vaccine | Vaccine comprised of purified capsular polysaccharide antigen from 23 types of Streptococcus pneumoniae (representing those types responsible for most of the reported pneumococcal diseases in the U.S.). (05 Mar 2000) |
| poliovirus vaccine | A suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used in the united states only for immunization of immunologically deficient patients and for primary immunization of unimmunised adults at risk. (12 Dec 1998) |